All currency values in $ millions unless otherwise noted
Scroll
| Income Statement | TTM | OCT 2025 | OCT 2024 | OCT 2023 | OCT 2022 | OCT 2021 |
|---|---|---|---|---|---|---|
| Revenues | ||||||
| Revenue | $9 | $9 | $10 | $17 | $19 | $20 |
| Cost of Revenue | $6 | $6 | $7 | $12 | $15 | $15 |
| Gross Profit | $3 | $3 | $3 | $5 | $5 | $5 |
| General & Administrative | $3 | $4 | $4 | $4 | $4 | $9 |
| Total Operating Expenses | $10 | $10 | $11 | $16 | $18 | $24 |
| Operating Income | -$0 | -$1 | -$1 | $1 | $1 | -$4 |
| Non-Operating | ||||||
| Net Interest Expense | – | $0 | $0 | $0 | $0 | – |
| Other Non-Operating Income (Expense) | $0 | $1 | $0 | $0 | $0 | $2 |
| EBT (Earnings Before Tax) | $0 | -$0 | -$1 | $2 | $1 | -$2 |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Earnings from Continuing Ops | -$0 | -$1 | -$1 | $1 | $1 | – |
| Net Income | ||||||
| Net Income | $0 | -$0 | -$1 | $1 | $1 | -$2 |
| Per Share Data | ||||||
| Revenue Per Share | $0.41 | $0.39 | $0.41 | $0.74 | $0.84 | $0.87 |
| EPS (Basic) | $0.01 | -$0.00 | -$0.03 | $0.06 | $0.04 | -$0.09 |
| EPS (Diluted) | $0.01 | -$0.00 | -$0.03 | $0.06 | $0.04 | -$0.09 |
| Weighted Avg Shares (Basic) | 22.9M | 22.9M | 23.0M | 23.0M | 23.0M | 23.0M |
| Weighted Avg Shares (Diluted) | 22.9M | 23.0M | 23.0M | 23.0M | 23.0M | 23.2M |
| Shares Outstanding | 22.9M | 23.0M | 23.0M | 23.0M | 23.0M | 23.2M |
| Dividends Per Share | – | $0.07 | $0.07 | $0.07 | $0.15 | $0.07 |
Pharma-Bio Serv (PBSV) financials: revenue, profit and margins
Pharma-Bio Serv (PBSV) generated about $9 million in revenue and $251,525.00 in net income (a 2.7% net margin) over the trailing twelve months, growing at roughly -16.0% a year. Figures are from SEC filings; this is analysis, not investment advice.
Frequently asked
What is Pharma-Bio Serv's (PBSV) revenue?+
Pharma-Bio Serv generated about $9 million in revenue over the trailing twelve months. Revenue has grown at roughly -16.0% a year over the past five years. Revenue is the top line, before any costs; what matters for value is how much of it survives to free cash flow. The full income statement, balance sheet and cash-flow statement are on this tab.
Is Pharma-Bio Serv profitable?+
Yes, Pharma-Bio Serv reported about $251,525.00 in net income over the trailing twelve months, a net profit margin of roughly 2.7%. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.
What are Pharma-Bio Serv's profit margins?+
Pharma-Bio Serv runs a gross margin of about 32.3%, an operating margin of about -1.6%, a net margin of about 2.7%. Margins show how much of each sales dollar a company keeps at each stage. Stable or rising margins usually signal pricing power and cost discipline; falling margins are worth investigating. See the multi-year trend on this tab.
How fast is Pharma-Bio Serv growing?+
Pharma-Bio Serv's revenue has compounded at roughly -16.0% a year over the past five years. Growth only creates value when it is profitable and cash-generative, so read this rate alongside PBSV's margins and free cash flow. This is analysis from SEC filings, not investment advice.
SourceFinancial statements computed from the 10-Q filed 10 Sept 2026, covering the period ending 31 Jul 2026, as reported to the SEC. Data last refreshed 3 Oct 2026. How this is calculated.
Fiscal year ends Oct.
Peers
Services-Management Consulting Services · Pick stocks to compare with PBSV
Spot a number that looks wrong? Check it in PBSV's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing PBSV
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.